Article | May 20, 2016

Removing Unnecessary Risk From Clinical Trials Throughout The Chain Of Custody

Removing Unnecessary Risk From Clinical Trials Throughout The Chain Of Custody

The successful execution of clinical trials involves coordinating a myriad of resources and processes. Among these challenges is the management of the global clinical supply chain, including complete traceability across the entire chain of custody. Maintaining visibility into the chain of custody can be challenging for many reasons, as can providing the level of data integrity and traceability required by regulatory authorities. Gaps in today’s processes, such as disparate data systems with little or no integration, supply management as a low priority for site staff, and frequent site monitor and CRA turnover all combine to create serious risk in the chain of custody.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader